Ahmed Elkamhawy

Minia University

H指数:26

被引数:2,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liquid-assisted grinding (LAG) as sustainable high yielding method for s-triazine hybrids synthesis: their docking, in vitro antimicrobial and anti-biofilm studies

液相辅助研磨(LAG)作为合成三嗪杂化物的可持续高产方法：其对接、体外抗菌和抗生物膜研究

Royal Society Open Science

IF2.9

2026-05-010

PRE

Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity

新型取代喹唑啉-2,4(1H,3H)-二酮类苯甲酰肼衍生物的合成与生物活性评价：作为具有潜在抗增殖活性的选择性PARP-1抑制剂

Journal of Molecular Structure

IF4.7

2025-08-190

OAAI

The interplay involving oxidative stress and autophagy: Mechanisms, implications, and therapeutic opportunities

氧化应激与自噬的相互作用：机制、意义及治疗机会

Experimental and Molecular Pathology

IF3.7

2025-08-010

OAAI

Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening

新型萘基二芳酰胺作为泛Raf激酶抑制剂的发现及其抗黑色素瘤活性的研究：理性设计、合成、体外及计算机筛选

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2025-02-080

Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets

PHARMACEUTICALS

IF4.8

2024-12-140

OAAI

Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase

MOLECULAR DIVERSITY

IF3.8

2024-05-102

PRE

2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (vol 12, 876, 2022)

LIFE-BASEL

IF3.4

2024-03-220

OAAI

Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments

糖尿病: 分类，介质和并发症; 确定开发新的有效治疗方法的潜在目标的大门

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-12-0158

OAAI

Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives

Inflammopharmacology

IF5.3

2023-11-110

PRE

Visible-light-assisted base-catalyzed, one-pot synthesis of highly functionalized cinnolines

GREEN PROCESSING AND SYNTHESIS

IF3

2023-11-030

Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer-Design, Synthesis, and In Vitro Evaluation

ACS OMEGA

IF4.3

2023-08-238

OAAI

Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2023-08-1814

OAAI

Recent developments in the synthesis of hybrid heterocycles, a promising approach to develop multi-target antibacterial agents

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2023-08-0118

PRE

Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2023-05-1117

OAAI

Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2023-04-255

OAAI

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2023-01-2618

OAAI

Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations

METABOLITES

IF3.7

2023-01-1710

OAAI

Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives

PHARMACEUTICALS

IF4.8

2022-12-2811

OAAI

Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-12-1636

PRE

Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson?s disease via the activation of Nrf2/HO-1 signaling

新型异黄酮J衍生物作为有效的神经保护剂，通过激活Nrf2/HO-1信号传导治疗帕金森氏病

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-11-015

PRE

Ahmed Elkamhawy

个人简介

教育背景

工作经历

荣誉奖项

研究方向